Search Tag: ICD
2024 30 Jul
Patients with congestive heart failure (CHF) who have impaired blood supply are at a higher risk of sudden cardiac death (SCD), with an estimated incidence of up to 22%. Current clinical guidelines recommend implantable cardioverter defibrillators (ICDs) to reduce this risk. However, these guidelines are based on studies that did not include individuals...Read more
2021 27 Apr
New findings presented at EHRA 2021 show that patients who receive an implantable cardioverter defibrillator (ICD) are at a higher risk of anxiety and depression and should be regularly screened. Study authors explain that most patients adjust well to living with an ICD, but it can be a life-changing experience for some. Worries about shock from...Read more
2020 25 Jun
In the early phase of the COVID-19 pandemic, it was observed that patients with SARS-CoV-2 seem to have a higher rate of cardiac arrhythmias. Hospitals from China reported this to be 17% in hospitalised patients and as high as 44% in those placed in intensive care units. Similar reports were shared from Italy and New York as well. To study this...Read more
2019 01 May
Implantable cardioverter-defibrillators (ICDs) are one of the most effective treatments that is used to prevent sudden cardiac death in patients at risk for potentially lethal ventricular arrhythmias. However, despite the clinical benefits, the risk of developing psychosocial issues is very high ICD patients, including anxiety (reported prevalence...Read more
2017 11 Jun
Findings from a four-year study of athletes with implantable defibrillators (ICDs) confirms that competitive sports may be okay for many of these athletes. The findings are published in the journal Circulation. ICDs are commonly used in patients with arrhythmia. The American Heart Association issued a scientific statement in 2015 advising that participating...Read more
2016 04 Jan
Approximately 30,000 people in the UK and 326,000 people in the US experience an out-of-hospital cardiac arrest each year. The implantable cardioverter defibrillator (ICD) is used to give an internal electrical shock to the heart within 10 to 15 seconds of an arrest. This reduces the risk of sudden cardiac death and is considered to be the gold standard...Read more
2015 28 Jun
According to a study published in JAMA Internal Medicine, the current monitoring of patients with cardiac implantable electronic devices (CIEDs) such as pacemakers and defibrillators may be underestimating device problems. Researchers from the University of California propose systematic methods to determine accurate causes of sudden death in those...Read more
2014 26 Aug
Michael Glikson, MD is the Director of the Davidai Arrhythmia Center in Tel Hashomer, Israel, operating under the auspices of Chaim Sheba Medical Center’s Heart Treatment and Research Center. Prof. Glikson established the institute in 2010 after leading Sheba Medical Center’s electrophysiology (EP) and pacing unit since 2002. The centre is the largest...Read more
2014 10 Jun
Psychosocial factors such as anxiety, depression or low social status not only increase risk for cardiovascular disease, but lead to worse prognosis after disease onset. Evidence for the importance of psychosocial factors in cardiology is outlined in an updated position paper from the German Society of Cardiology “Deutsche Gesellschaft für Kardiologie...Read more
2014 08 Jun
The preventive placement of an implantable cardioverter-defibrillator (ICD) benefits patients with less severe levels of heart failure, with significantly better survival three years after implantation, a study in JAMA’s 4 June issue reports. The research focuses on a population not often studied in clinical trials, with results supporting the use...Read more
2014 11 Feb
Cardiology experts discuss studies showing time as an important factor in the treatment of heart conditions Experts in cardiology and electrophysiology met at this year’s 8th annual EMB (Expert Meeting Berlin) Conference to discuss critical issues affecting their fields. Among the topics addressed were: How can remote monitoring and early...Read more
2014 17 Jan
New findings from the ECOST study underscore the economic benefits of Biotronik Home Monitoring for the French National Health Insurance system Biotronik Home Monitoring significantly reduces the cost of follow-up in patients with implantable defibrillators (ICDs). New data from the ECOST (Effectiveness and Cost of ICD Follow-Up Schedule...Read more